ImageneBio, Inc. (IMA) Free cash flow 2020–2023
ImageneBio, Inc. (IMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$80.2MFY2023 · since FY2020: -$38.6M → -$80.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$80.2M | -6.1% |
| FY2022 | -$75.5M | -21.8% |
| FY2021 | -$62.0M | -60.7% |
| FY2020 | -$38.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice